Barclays PLC acquired a new position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 17,082 shares of the company's stock, valued at approximately $479,000. Barclays PLC owned approximately 0.05% of Bowhead Specialty as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. American Century Companies Inc. acquired a new position in Bowhead Specialty during the 2nd quarter valued at about $23,148,000. Sei Investments Co. acquired a new position in shares of Bowhead Specialty during the second quarter valued at about $2,021,000. Interval Partners LP acquired a new stake in shares of Bowhead Specialty during the second quarter worth $582,000. Davidson Kempner Capital Management LP purchased a new position in Bowhead Specialty in the 2nd quarter worth $253,000. Finally, Point72 DIFC Ltd purchased a new position in shares of Bowhead Specialty in the second quarter worth about $782,000.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the stock. Royal Bank of Canada raised their price target on shares of Bowhead Specialty from $32.00 to $35.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 6th. JPMorgan Chase & Co. upped their price target on shares of Bowhead Specialty from $26.00 to $30.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. JMP Securities lifted their price objective on Bowhead Specialty from $32.00 to $33.00 and gave the company a "market outperform" rating in a research note on Wednesday, November 6th. Finally, Keefe, Bruyette & Woods upped their target price on Bowhead Specialty from $36.00 to $44.00 and gave the stock a "market perform" rating in a research note on Friday, January 10th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $33.60.
Check Out Our Latest Report on BOW
Bowhead Specialty Price Performance
Shares of Bowhead Specialty stock traded up $0.54 on Friday, hitting $33.16. The company's stock had a trading volume of 91,484 shares, compared to its average volume of 157,087. The firm has a fifty day moving average price of $34.64 and a 200-day moving average price of $30.74. Bowhead Specialty Holdings Inc. has a 1 year low of $22.14 and a 1 year high of $37.81.
Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.38 EPS for the quarter, hitting the consensus estimate of $0.38. The company had revenue of $116.76 million during the quarter, compared to analysts' expectations of $113.00 million. Sell-side analysts predict that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Bowhead Specialty news, Director Family Mutual Insuran American sold 1,362,285 shares of Bowhead Specialty stock in a transaction on Friday, October 25th. The shares were sold at an average price of $27.70, for a total transaction of $37,735,294.50. Following the sale, the director now owns 4,700,761 shares of the company's stock, valued at $130,211,079.70. The trade was a 22.47 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Bowhead Specialty Company Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.